| Literature DB >> 25980994 |
Shoichi Sasaki1, Soichi Sasaki1, Takenari Yamashita2, Shin Kwak3, Kwak Shin3.
Abstract
In the motor neurons of amyotrophic lateral sclerosis (ALS) patients, an RNA editing enzyme called adenosine deaminase acting on RNA 2 (ADAR2) is down-regulated and consequently GluA2 mRNAs unedited at the Q/R site is expressed in contrast to normal motor neurons that express only GluA2 edited at this site. Motor neurons of the mice lacking ADAR2 undergo Ca(2+)-permeable AMPA receptor-mediated slow death. We investigated the spinal cords of conditional ADAR2-knockout mice modeling ALS for the involvement of autophagy. In the motor neurons of the early- and late-symptomatic-stage mice, LC3-immunopositivity or immunoreactivity for both LC3- and p62 was observed, whereas the presymptomatic-stage mice showed no LC3- or p62-immunoreactivity. Western blot analyses showed increased expression of autophagy associated proteins in the anterior horn of the early symptomatic-stage mice. Electron-microscopically, autophagy was observed in the motor neurons most frequently in the early-symptomatic-stage mice which showed the severest motor neuron degeneration. Increased autophagy flux was not recognized in the wild-type mice or AR2res (ADAR2(flox/flox)/VAChT-Cre. Fast/GluR-B(R)(/)(R)) mice having motor neurons genetically engineered to express normally edited GluA2 in the absence of ADAR2, which show normal Ca(2+)-permeability of the AMPA receptors in motor neurons. Significantly increased autophagy flux in the degenerating motor neurons of ADAR2-knockout mice likely resulted from Ca(2+) overload.Entities:
Keywords: ADAR2-knockout mice; AMPA receptor; Amyotrophic lateral sclerosis; Autophagy; Calcium; LC3
Mesh:
Substances:
Year: 2015 PMID: 25980994 DOI: 10.1016/j.neulet.2015.05.025
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046